Research Summary
Researchers administered the GHK peptide intranasally to aging mice and assessed its effects on cognitive function and resilience to decline. The study found that intranasal GHK peptide treatment was associated with enhanced cognitive resilience and reduced cognitive decline in the aging mouse model. This is an **animal model study** with potential relevance to understanding peptide-based approaches in aging, though findings require validation in human populations before clinical application.